Response to Entecavir(ETV)in patients with Chronic Hepatitis B(CHB)and primary non-response to Adefo

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:bosimao_wang
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Elevated HBV DNA levels are associated with increased risk for liver cancer and cirrhosis.Rapid and complete viral suppression correlates with lower rate of resistance development.Effectiveness of switching to ETV in patients with primary non-response to ADV are limited.
其他文献
近年来,由于生活水平提高和医疗条件改善及抗生素的及时和广泛使用,典型风湿热在我国尤其是城市中已较少见[1].除儿童风湿专科医师,其他儿科临床医师对该病认识仍有限.本文报道1例以舞蹈病为主要表现的儿童风湿误诊病例,希望引起临床关注.
Background:Several association studies with small sample sizes of two SNPs in IL28B(rs12979860 and rs8099917) showed inconsistent results,so in this study,we aim to evaluate the association of two SNP
会议
Background:To compare the 2-year efficacy and safety of de novo combination therapy with lamivudine(LAM)and adefovir dipivoxil(ADV) to that of entecavir(ETV)monotherapy in treatment of patients with c
会议
Background:Invariant natural killer T cells(iNKT) have been demonstrated to participate in the pathogenesis of alcoholic liver disease in mouse model;however,little is known regarding their immune-pat
会议
Background:Hepatitis B virus(HBV) induced hepatic inflammation can threaten the human health and is associated with the progression of liver cirrhosis and cancer.
会议
Objectives:To find a biomarker to predict the prognosis of acute on chronic hepatitis B liver failure(ACHBLF).Methods:This study included 63 patients with ACHBLF,60 patients with chronic hepatitis B(C
会议
Background:Liver biopsy is recommended before therapy for patients with HBeAg-positive chronic hepatitis B(CHB) when alanine aminotransferase(ALT) Less than or equal to2upper limit of normal(ULN) and
会议
Background:In order to manage the healthcare quality and reduce mortality of hepatitis B virus(HBV) related liver failure,a prospective multicenter study was performed in 10 large liver center in Chin
会议
Background:Interleukin-33(IL-33) and soluble ST2(sST2) have been demonstrated to be associated with liver injury.
会议
Background:Protective immune response plays an important role in eliminating HBV infection.A weak immune response to HBV can lead to chronic liver disease.
会议